3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Breast
1
Conditions
Prostatic Neoplasms
16
Urogenital Neoplasms
2
Urinary Bladder Neoplasms
2
Urothelial Cancer
1
Urologic Neoplasms
1
Urologic Diseases
1
Urogenital Diseases
1
Urinary Bladder Diseases
1
Radiation Injuries
1
Prostate Adenocarcinoma
1
Neoplasms by Site
1
Neoplasms
1
Melanoma
1
Male Urogenital Diseases
1
Lymphatic Metastasis
1
Infiltrating Bladder Urothelial Carcinoma
1
Genital Neoplasms, Male
1
Female Urogenital Diseases
1
Encopresis
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Specimen Handling
2
Radiotherapy, Intensity-Modulated
2
Radiosurgery
2
Magnetic Resonance Spectroscopy
2
radium Ra 223 dichloride
1
peposertib
1
fluoroazomycin arabinoside
1
cabozantinib
1
avelumab
1
Radiotherapy, Image-Guided
1
Radiation Dose Hypofractionation
1
PITX2 protein, human
1
Nomograms
1
Nivolumab
1
Metastasectomy
1
Leuprolide
1
Ipilimumab
1
Indocyanine Green
1
Goserelin
1
Docetaxel
1
DEAE-Dextran
1
CTLA-4 Antigen
1
Artificial Intelligence
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphatic Metastasis
×
Radiation Dose Hypofractionation
×
Genitourinary
×
Clear all
NCT03796767
2026-01-28
SOAR
University of Utah
Phase 2
Active not recruiting
20 enrolled
26 charts